Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 2

1(20.0%)

5Total

N/A(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04288245Not ApplicableActive Not Recruiting

Targeted Plasticity Therapy for Upper Limb Rehabilitation in Spinal Cord Injuries

Role: collaborator

NCT04520178Phase 2Recruiting

Effects of 5HTP on the Injured Human Spinal Cord

Role: collaborator

NCT04565366Enrolling By Invitation

Transforming Research and Clinical Knowledge in Spinal Cord Injury

Role: collaborator

NCT05462925Not ApplicableCompleted

Prediction of Muscle Responsiveness to FES Therapy

Role: collaborator

NCT03053791Not ApplicableRecruiting

Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait

Role: collaborator

NCT05638191Unknown

Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury

Role: collaborator

NCT03954496Not ApplicableTerminated

Improving Hand Recovery With Neuromodulation in Tetraplegia

Role: collaborator

NCT03336762Completed

Injured Spinal Cord Pressure Evaluation Study - Transverse Myelitis

Role: collaborator

All 8 trials loaded